A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

被引：0
|
作者：
Nicolas Roussot
Jean-David Fumet
Emeric Limagne
Marion Thibaudin
Alice Hervieu
Audrey Hennequin
Sylvie Zanetta
Lorraine Dalens
Théo Fourrier
Loick Galland
Pierre Jacob
Aurélie Bertaut
Emilie Rederstorff
Cédric Chevalier
Sarah Ghirardi
Elodie Gilbert
Azzat Khoukaz
Etienne Martin
Constance Nicolet
Magali Quivrin
David Thibouw
Noémie Vulquin
Gilles Truc
Magali Rouffiac
Francois Ghiringhelli
Céline Mirjolet
机构：
[1] Center Georges François Leclerc,Department of Medical Oncology
[2] Center GF Leclerc,Department of Radiotherapy
[3] Cancer Biology Transfer Platform,Department of Epidemiology and Biostatistics
[4] GIMI Genetic and Immunology Medical Institute,Radiation Oncology Department, Preclinical Radiation Therapy and Radiobiology Unit
[5] University of Burgundy-Franche Comté,undefined
[6] UMR INSERM 1231,undefined
[7] Center GF Leclerc,undefined
[8] Center GF Leclerc,undefined
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; Renal cell cancer; Bladder cancer; Head and neck cancer; PDL-1; TIGIT; Atezolizumab; Tiragolumab; Stereotactic body radiation therapy; SBRT; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Phase I/II Trial Evaluating the Combination of Stereotactic Body Radiotherapy and Pembrolizumab in Metastatic NSCLC
    Decker, Roy
    Goldberg, Sarah
    Nath, Sameer
    Husain, Zain
    Lilenbaum, Rogerio
    Schalper, Kurt
    Chiang, Anne
    Altan, Mehmet
    Zelterman, Daniel
    Kaech, Susan
    Herbst, Roy
    Gettinger, Scott
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1303 - S1304
  • [42] A Phase I Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma
    Sebastian, N.
    Miller, E. D.
    Yang, X.
    Dowell, J.
    Pardo, D. A. Diaz
    Spain, J.
    Rikabi, A.
    Elliott, E.
    Knopp, M.
    Williams, T. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S208 - S208
  • [43] Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors (jan, 10.1007/s00280-023-04627-3, 2024)
    Yamamoto, Noboru
    Koyama, Takafumi
    Sato, Jun
    Yoshida, Tatsuya
    Sudo, Kazuki
    Iwasa, Satoru
    Kondo, Shunsuke
    Yonemori, Kan
    Kawasaki, Atsuko
    Satake, Kyoko
    Shibata, Shoyo
    Shimizu, Toshio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (03) : 491 - 491
  • [44] Stereotactic body radiation therapy for prostate cancer
    Ishiyama, Hiromichi
    Teh, Bin S.
    Lo, Simon S.
    Mathews, Thomas
    Blanco, Angel
    Amato, Robert
    Ellis, Rodney J.
    Mayr, Nina A.
    Paulino, Arnold C.
    Xu, Bo
    Butler, Brian E.
    FUTURE ONCOLOGY, 2011, 7 (09) : 1077 - 1086
  • [45] A Comparison of Standard Fractionation and Stereotactic Body Radiation Therapy in the Treatment of Metastatic Breast Cancer
    Merrell, K. W.
    Barney, B. M.
    Yan, E.
    Laack, N. N.
    Olivier, K. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S232 - S233
  • [46] Stereotactic Body Radiation Therapy for Lung Cancer
    Simone, Charles B., II
    Wildt, Brian
    Haas, Andrew R.
    Pope, Greg
    Rengan, Ramesh
    Hahn, Stephen M.
    CHEST, 2013, 143 (06) : 1784 - 1790
  • [47] Does stereotactic body radiation therapy have a role in oligoprogressive metastatic colorectal cancer?
    Jin, Will
    Burke, Aidan M.
    Rashid, Abdul
    Marshall, John
    Unger, Keith Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [48] Stereotactic Body Radiation Therapy for Pancreatic Cancer
    Goodman, Karyn A.
    CANCER JOURNAL, 2016, 22 (04): : 290 - 295
  • [49] Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study
    Ahmed, K. A.
    Quick, A. M.
    Bixel, K.
    Kim, Y.
    Lemerond, E.
    Chon, H. S.
    Chern, J. Y.
    Fernandez, D. C.
    Hoffman, M. S.
    Kim, S.
    Lam, C.
    Montejo, M. E.
    Shahzad, M. M.
    Wenham, R. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S89 - S90
  • [50] Randomized phase 2 study of nivolumab with or without ipilimumab in combination with stereotactic body radiotherapy in patients with refractory metastatic pancreatic cancer (CHECKPAC)
    Chen, Inna Markovna
    Johansen, Julia S.
    Theile, Susann
    Hjaltelin, Jessica X.
    Novitski, Sif I.
    Brunak, Soren
    Hasselby, Jane P.
    Willemoe, Gro L.
    Lorentzen, Torben
    Madsen, Kasper
    Jensen, Benny V.
    Wilken, Eva E.
    Geertsen, Poul F.
    Behrens, Claus
    Nolsoe, Christian
    Hermann, Kirstine L.
    Svane, Inge Marie
    Nielsen, Dorte
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345